Literature DB >> 17038018

Correlation of echocardiography parameters with cardiac magnetic resonance imaging in transfusion-dependent thalassaemia major.

Athanassios Aessopos1, Anastasios Giakoumis, Christina Fragodimitri, Fotis Karabatsos, Antonia Hatziliami, Jacqueline Yousef, Efstathios Gotsis, Vasilis Berdoukas, Markissia Karagiorga.   

Abstract

BACKGROUND AND
OBJECTIVE: Heart iron load (cardiac Fe) can be indirectly quantified by cardiac magnetic resonance (CMR) T2*. CMR accessibility is limited, whereas echocardiography (Echo) is relatively inexpensive and readily available. The objective was to find Echo parameters that may be useful for predicting cardiac Fe. DESIGN AND METHODS: We compared a number of parameters derived from Echo to cardiac Fe in 142 thalassaemia major patients who had undergone a CMR study.
RESULTS: All patients with decreased left ventricular (LV) function had cardiac Fe. After removing those patients from the analysis, the total diameter index (Tdi) >5.57 cms/m2, left atrial diameter index >2.41 cm/m2, and the diastolic parameter E/A > 1.96 were highly specific (91.4%, 97.1% and 96.9% respectively) but had low sensitivity (31.8%, 20.45% and 21.8%) in predicting iron load. A right ventricular index >1.47 cm/m2, LV systolic index >2.26 cm/m2 or Tdi >6.26 cm/m2 discriminated between patients with no, or mild to moderate cardiac Fe from those with heavy load, with specificity of 91%, 98.5%, and 98.5%, respectively, but with low sensitivity. INTERPRETATION AND
CONCLUSIONS: Echo parameters for cardiac Fe prediction have restricted value, whereas CMR is essential to assess cardiac Fe. However, patients with decreased LV systolic function should be considered a priori as having cardiac Fe, and chelation therapy should be intensified. This also applies to patients who have the above-described Echo criterion values, even if CMR is not available. Once a patient is found by CMR to have cardiac Fe, then the above Echo criterion values may be useful for ongoing monitoring.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038018     DOI: 10.1111/j.1600-0609.2006.00770.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.

Authors:  Srikanth R Ambati; Rachel E Randolph; Kevin Mennitt; Dorothy A Kleinert; Jonathan W Weinsaft; Patricia J Giardina
Journal:  Am J Hematol       Date:  2013-06-28       Impact factor: 10.047

2.  Comparison of Doppler echocardiographic and tissue Doppler velocity data in beta-thalassaemia major with high and normal NT-proBNP levels of children in the south-east region of Turkey.

Authors:  Derya Özyörük; Taliha Öner; Yeşim Oymak; Hüseyin Tuğrul Çelik
Journal:  Transl Pediatr       Date:  2014-10

3.  Prevention of cardiomyopathy in transfusion-dependent homozygous thalassaemia today and the role of cardiac magnetic resonance imaging.

Authors:  Athanassios Aessopos; Vasilios Berdoukas; Maria Tsironi
Journal:  Adv Hematol       Date:  2009-04-29

Review 4.  MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Authors:  Maria I Argyropoulou; Loukas Astrakas
Journal:  Pediatr Radiol       Date:  2007-08-21

Review 5.  The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.

Authors:  Athanassios Aessopos; Vasilios Berdoukas; Maria Tsironi
Journal:  Eur J Haematol       Date:  2007-12-10       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.